Wednesday, July 8, 2026

Patent intelligence · US

US 9675653

Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

granted A61KA61K2236/00A61K31/01A61K36/15
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 11
Applicant portfolio 95
Related coverage 1
Patent details — US 9675653

Quick answer

US 9675653 (Composition containing an essential oil product and method for using such to maintain normal levels of testosterone) is held by YOUNG LIVING ESSENTIAL OILS, LC. Status: granted. Granted Jun 13, 2017. Expires Jun 8, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
8
CPC classes
A61K, A61K2236/00, A61K31/01, A61K36/15, A61K45/06, A61K47/44

More from YOUNG LIVING ESSENTIAL OILS, LC

Related pharmaceutical patents in our USPTO index.

  1. US 12419895

    Methods for treating subjects with Prader-Willi syndrome

    ESSENTIALIS, INC. · Expires Sep 18, 2045

    granted
  2. US 12350258

    Compositions and methods for treatment of skin-related diseases and promoting dermatological health

    Script Essentials, LLC · Expires Jul 3, 2045

    granted
  3. US 12343348

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Expires Jun 26, 2045

    granted
  4. US 12343381

    Dosage regimen for pegylated interferon

    PHARMAESSENTIA CORPORATION · Expires Jun 26, 2045

    granted
  5. US 12178823

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Expires Dec 26, 2044

    granted
  6. US 12109216

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    ESSENTIALIS, INC. · Expires Oct 3, 2044

    granted
  7. US 12005081

    Chimeric receptors and methods of use thereof

    Senti Biosciences, Inc. · Expires Jun 6, 2044

    granted
  8. US 11884656

    Pyrrole derivatives as PLK1 inhibitors

    SENTINEL ONCOLOGY LIMITED · Expires Jan 25, 2044

    granted

Related coverage

Frequently asked questions

What is US patent 9675653?

US 9675653 (Composition containing an essential oil product and method for using such to maintain normal levels of testosterone) is held by YOUNG LIVING ESSENTIAL OILS, LC. Status: granted. Granted Jun 13, 2017. Expires Jun 8, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9675653?

YOUNG LIVING ESSENTIAL OILS, LC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.

When does US 9675653 expire?

Our index shows an expiration date of Jun 8, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.